These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2140503)

  • 1. Inhibition of thrombus formation in vivo by novel antiplatelet agent.
    Marzec UM; Kelly AB; Hanson SR; Lasslo A; Harker LA
    Arteriosclerosis; 1990; 10(3):367-71. PubMed ID: 2140503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
    Cadroy Y; Houghten RA; Hanson SR
    J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
    Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons.
    Hanson SR; Kotze HF; Savage B; Harker LA
    Arteriosclerosis; 1985; 5(6):595-603. PubMed ID: 2934045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.
    Gollamudi R; Dillingham EO; Bond SE; Lyman BA
    Biochem Biophys Res Commun; 1991 Jun; 177(2):888-93. PubMed ID: 2049109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time.
    Mazur C; Tschopp JF; Faliakou EC; Gould KE; Diehl JT; Pierschbacher MD; Connolly RJ
    J Lab Clin Med; 1994 Oct; 124(4):589-99. PubMed ID: 7523555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons.
    Schaffer LW; Davidson JT; Siegl PK; Gould RJ; Nutt RF; Brady SF; Connolly TM
    Arterioscler Thromb; 1993 Nov; 13(11):1593-601. PubMed ID: 8218100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist.
    Kotzé HF; Lamprecht S; Badenhorst PN; van Wyk V; Roodt JP; Alexander K
    Thromb Haemost; 1993 Oct; 70(4):672-5. PubMed ID: 8115994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates.
    Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA
    Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin.
    Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates.
    Cadroy Y; Hanson SR; Harker LA
    Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective antiplatelet actions of nipecotamides.
    Gollamudi R; Feng Z; Dillingham EO; Bond SE; Han G; Salgia S
    Thromb Res; 1993 Feb; 69(4):361-7. PubMed ID: 8470057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons.
    Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA
    Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
    Han G; Bannerman D; Handa RK; Dillingham EO; Lawrence WH; Gollamudi R
    Gen Pharmacol; 1997 Apr; 28(4):617-21. PubMed ID: 9147034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet adhesion and thrombus formation on a collagen-coated surface by novel carbamoylpiperidine antiplatelet agents.
    Alevriadou BR; McIntire LV; Lasslo A
    Biochim Biophys Acta; 1992 Nov; 1137(3):279-86. PubMed ID: 1445929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.
    Handa RK; Dillingham EO; Gollamudi R
    Life Sci; 1995; 57(10):983-8. PubMed ID: 7643723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
    Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
    Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
    Lasslo A; White JG
    Biochim Biophys Acta; 1984 Oct; 777(1):37-40. PubMed ID: 6435673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.